hepatitis-c

Documents about hepatitis-c

• A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV#863130ClinicalTrials.gov
• Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling#863421ClinicalTrials.gov
• Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs#903544ClinicalTrials.gov
• A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults#979477ClinicalTrials.gov
• The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects#1007306ClinicalTrials.gov
• Intraoperative pain sensitivity and aqueous humor inflammatory cytokine profiles in hepatitis C virus antibody-positive cataract patients.#255152NCBI PubMed Central
• eHealth Partnered Evaluation Initiative - Evaluation of the Initial Deployment of VA's Annie Texting System#303681ClinicalTrials.gov
• The Nonstructural 5A Protein of Hepatitis C Virus Genotype 1b Does Not Contain an Interferon Sensitivity–Determining Region#315047HAL (France)
• Real-World Effectiveness of All-Oral Direct-Acting Antivirals in Patients With Hepatitis C Virus-Related HCC.#334925NCBI PubMed Central
• lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C#465628Repositório Institucional Unesp
• Analysis of California Assembly Bill 1843: Communicable Diseases: Hepatitis B and C#624284eScholarship
• Awareness of hepatitis C knowledge among four high-risk populations in Xiamen, China: a cross-sectional study.#645254NCBI PubMed Central
• Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)#806957ClinicalTrials.gov
• 4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients#835487ClinicalTrials.gov
• Phase 3 Study of Sofosbuvir and Ribavirin#848530ClinicalTrials.gov
• Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life#851336ClinicalTrials.gov
• Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy#865120ClinicalTrials.gov
• Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients#899125ClinicalTrials.gov
• Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating Women#914856ClinicalTrials.gov
• Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin#1009449ClinicalTrials.gov
• Hepatitis B and C viral infections among blood donors. A retrospective study from a rural community of Ghana#274855KNUSTSpace
• Population-based prevalence and screening gaps of hepatitis C, B and D, Germany, 2020 to 2021.#320561NCBI PubMed Central
• Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants#366663ClinicalTrials.gov
• A multi-domain qualitative study on factors influencing access to preventive hepatitis B care among rural population.#421288NCBI PubMed Central
• Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial#446718PubMed Central
• Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment#833473ClinicalTrials.gov
• A Study of Drug-drug Interaction Between Ritonavir and TMC435350 in Healthy Volunteers#857392ClinicalTrials.gov
• To Study the Efficacy and Safety of Renessans in Chronic HCV Patients#875885ClinicalTrials.gov
• Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa#879226ClinicalTrials.gov
• Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia#1010069ClinicalTrials.gov
• Mild Hypothermia and Acute Kidney Injury in Liver Transplantation#825517ClinicalTrials.gov
• Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection#902612ClinicalTrials.gov
• Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)#841591ClinicalTrials.gov
• Seroprevalence and risk factors of HBV/HCV/HIV triple co-infection among HIV patients receiving HAART at a Tertiary Hospital in Makurdi, Nigeria#1055408ULRR
• Hepatitis C distribution across diverse population groups in the Eastern Mediterranean Region: An umbrella review#130441Unpaywall
• Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin#148712ClinicalTrials.gov
• Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance#152345ClinicalTrials.gov
• The CUPID Project: Understanding and preventing hepatitis C transmission within heterosexual couples#190631UNSWorks Repository
• Perspectives of Caregivers of Kidney Transplant Recipients and Transplant Candidates About Kidneys From Donors With Hepatitis C Virus Infection.#323111NCBI PubMed Central
• Prediction of potential NS3-based T cell epitopes of hepatitis C virus by in-silico and in-vitro approach.#327010NCBI PubMed Central
• Results of the National Health Screening Program for Hepatitis C among 56-year-olds, Republic of Korea, 2025.#399847NCBI PubMed Central
• Informing the Equitable Implementation of Hepatitis C Interventions: Cost-Effectiveness Modeling in Rural Populations of People Who Inject Drugs.#483443NCBI PubMed Central
• Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation#813713ClinicalTrials.gov
• STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs#829433ClinicalTrials.gov
• Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects#890710ClinicalTrials.gov
• NIDDM and IR in Combination Therapy for CHC#894360ClinicalTrials.gov
• Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)#900229ClinicalTrials.gov
• Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects#904564ClinicalTrials.gov
• Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney Disease#915702ClinicalTrials.gov
• The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure#966273ClinicalTrials.gov